Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.6K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.6K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

648
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
648
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.1K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.1K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

546
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
546

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Novel, Robust, and Isocratic HPLC-UV Method for the Comprehensive Determination of Enantiomeric Impurity (R-Isomer) in Niraparib Drug Substance.

Chirality·2026
Same author

Genomic characterization and SNP analysis connect respiratory infections caused by <i>Mycobacterium intracellulare</i> with a pool facility.

Microbial genomics·2025
Same author

Respiratory diphtheria in the time of Omicron.

Communicable diseases intelligence (2018)·2024
Same author

A five-year analysis of latent tuberculosis infection in Queensland, 2016-2020.

Communicable diseases intelligence (2018)·2023
Same author

Setting the policy agenda for cancer control reform: Australia's first national cancer control plan.

The Medical journal of Australia·2023
Same author

Australian recommendations for the management of drug-resistant tuberculosis, 2023.

Communicable diseases intelligence (2018)·2023

Related Experiment Video

Updated: Feb 11, 2026

Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum
04:36

Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum

Published on: August 5, 2020

4.9K

Tuberculosis notifications in Australia, 2014.

Cindy Toms1, Richard Stapledon2, Chris Coulter3

  • 1Office of Health Protection, Department of Health, Canberra, ACT.

Communicable Diseases Intelligence Quarterly Report
|May 4, 2018
PubMed
Summary
This summary is machine-generated.

Australia maintains strong tuberculosis (TB) control with low incidence rates. However, sustained efforts are needed to further reduce TB, particularly among overseas-born and Indigenous populations, to meet global elimination goals.

More Related Videos

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis
08:48

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis

Published on: July 11, 2025

637
Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

7.8K

Related Experiment Videos

Last Updated: Feb 11, 2026

Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum
04:36

Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum

Published on: August 5, 2020

4.9K
Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis
08:48

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis

Published on: July 11, 2025

637
Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

7.8K

Area of Science:

  • Public Health
  • Infectious Disease Epidemiology
  • Communicable Disease Surveillance

Background:

  • Australia has maintained effective tuberculosis (TB) control since the mid-1980s, with incidence rates around 5-6 cases per 100,000 population.
  • Multi-drug resistant TB (MDR-TB) remains low, representing 1-2% of annual notifications.
  • TB disproportionately affects overseas-born individuals (86% of notifications) and Aboriginal and Torres Strait Islander peoples (rates ~6x higher).

Purpose of the Study:

  • To report on tuberculosis notifications in Australia for 2014.
  • To assess the current status of TB control in Australia.
  • To highlight key populations affected by TB and inform future control strategies.

Main Methods:

  • Analysis of tuberculosis (TB) notification data from the National Notifiable Diseases Surveillance System (NNDSS) for 2014.
  • Calculation of TB incidence rates per 100,000 population.
  • Comparison of TB rates across different demographic groups, including overseas-born and Indigenous populations.

Main Results:

  • In 2014, 1,339 TB notifications were received, yielding an incidence rate of 5.7 per 100,000 population.
  • The proportion of multi-drug resistant TB (MDR-TB) cases remained low.
  • Overseas-born individuals constituted the majority of TB notifications (86%), while Aboriginal and Torres Strait Islander populations experienced significantly higher TB rates.

Conclusions:

  • Australia demonstrates excellent and sustained control of tuberculosis (TB).
  • Targeted interventions are necessary to address the higher TB burden in overseas-born and Indigenous populations.
  • Continued efforts are crucial to further reduce TB incidence and contribute to the global goal of ending the TB epidemic by 2035.